Skip to main content

Advertisement

Log in

Administration of anti-thymocyte globulin: a comparison of two protocols

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.

    Article  CAS  Google Scholar 

  2. Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10: 855–864.

    Article  CAS  Google Scholar 

  3. Mathe G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M et al. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 1970; 2: 131–136.

    Article  CAS  Google Scholar 

  4. Guttmann RD, Caudrelier P, Alberici G, Touraine JL . Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression. Transplant Proc 1997; 29: 24S–26SS.

    Article  CAS  Google Scholar 

  5. Andersen J, Heilmann C, Jacobsen N, Nielsen C, Bendtzen K, Muller K . Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 635–640.

    Article  CAS  Google Scholar 

  6. Thymoglobulin Anti-Thymocyte Globulin (Rabbit) [package insert]. 2008, Genzyme Corporation: Cambridge, MA, USA.

  7. Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998; 66: 29–37.

    Article  CAS  Google Scholar 

  8. Weiden PL, Doney K, Storb R, Thomas ED . Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts. Transplantation 1979; 27: 227–230.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A B Clemmons.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clemmons, A., Hartranft, M., Kota, V. et al. Administration of anti-thymocyte globulin: a comparison of two protocols. Bone Marrow Transplant 49, 1535–1537 (2014). https://doi.org/10.1038/bmt.2014.174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.174

  • Springer Nature Limited

This article is cited by

Navigation